- Home
- ATCH vs TCRT Comparison
ATCH vs TCRT Comparison
Compare ATCH & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- TCRT
- Stock Information
- Founded
- ATCH 2022
- TCRT 1998
- Country
- ATCH United States
- TCRT United States
- Employees
- ATCH N/A
- TCRT N/A
- Industry
- ATCH
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- ATCH
- TCRT Health Care
- Exchange
- ATCH Nasdaq
- TCRT Nasdaq
- Market Cap
- ATCH 3.2M
- TCRT 3.8M
- IPO Year
- ATCH N/A
- TCRT N/A
- Fundamental
- Price
- ATCH $0.21
- TCRT $3.03
- Analyst Decision
- ATCH
- TCRT
- Analyst Count
- ATCH 0
- TCRT 0
- Target Price
- ATCH N/A
- TCRT N/A
- AVG Volume (30 Days)
- ATCH 7.7M
- TCRT 12.3K
- Earning Date
- ATCH 05-16-2025
- TCRT 05-15-2025
- Dividend Yield
- ATCH N/A
- TCRT N/A
- EPS Growth
- ATCH N/A
- TCRT N/A
- EPS
- ATCH 2.67
- TCRT N/A
- Revenue
- ATCH N/A
- TCRT $11,000.00
- Revenue This Year
- ATCH N/A
- TCRT $5,680,500.00
- Revenue Next Year
- ATCH N/A
- TCRT N/A
- P/E Ratio
- ATCH $0.08
- TCRT N/A
- Revenue Growth
- ATCH N/A
- TCRT 83.33
- 52 Week Low
- ATCH $0.18
- TCRT $1.31
- 52 Week High
- ATCH $83.99
- TCRT $11.00
- Technical
- Relative Strength Index (RSI)
- ATCH 33.79
- TCRT 60.98
- Support Level
- ATCH $0.19
- TCRT $2.50
- Resistance Level
- ATCH $0.23
- TCRT $2.80
- Average True Range (ATR)
- ATCH 0.02
- TCRT 0.21
- MACD
- ATCH 0.02
- TCRT 0.01
- Stochastic Oscillator
- ATCH 38.18
- TCRT 98.31
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.